Stuart W. Peltz, Ph.D.

Stuart W. Peltz, Ph.D.

Former Chief Executive OfficeratPTC Therapeutics· In proxies 2021–2023

Pay in FY2023-21% from the year before · PTC Therapeutics stock -27.8% the same year

Stuart W. Peltz, Ph.D. was paid $5.7M in FY2023 (Dec), down 21%. PTC Therapeutics stock fell 27.8% that year.

Pay$100 in the stock at the end of FY20 → $45
Pay is from the Summary Compensation Table of each PTC Therapeutics proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Experience

  1. PTC TherapeuticsPublic company · 5 yr
    • Former Chief Executive Officer2021 – Present · 5 yrStock in role -3%

Roles come from the proxy statements of each company.

Activity

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?